Cargando…
Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples
After more than two years, COVID-19 still represents a global health burden of unprecedented extent and assessing the degree of immunity of individuals against SARS-CoV-2 remains a challenge. Virus neutralization assays represent the gold standard for assessing antibody-mediated protection against S...
Autores principales: | Meyrath, Max, Szpakowska, Martyna, Plesseria, Jean-Marc, Domingues, Olivia, Langlet, Jérémie, Weber, Bernard, Krüger, Rejko, Ollert, Markus, Chevigné, Andy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459433/ https://www.ncbi.nlm.nih.gov/pubmed/36220277 http://dx.doi.org/10.1016/bs.mie.2022.07.015 |
Ejemplares similares
-
Proadrenomedullin N-Terminal 20 Peptides (PAMPs)
Are Agonists of the Chemokine Scavenger Receptor ACKR3/CXCR7
por: Meyrath, Max, et al.
Publicado: (2021) -
The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides
por: Meyrath, Max, et al.
Publicado: (2020) -
The natural analgesic conolidine targets the newly identified opioid scavenger ACKR3/CXCR7
por: Szpakowska, Martyna, et al.
Publicado: (2021) -
CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6
por: Chevigné, Andy, et al.
Publicado: (2021) -
The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-B
por: D’Uonnolo, Giulia, et al.
Publicado: (2022)